BP1210
Ritonavir
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 155213-67-5
Synonym(S): 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | BP1210-100-MG | In Stock | ₹ 21,401.03 |
BP1210 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 21,401.03
GST (18%): ₹ 3,852.185
Total Price: ₹ 25,253.215
grade
pharmaceutical primary standard
Quality Level
100
Agency
BP
API family
ritonavir
form
solid
shelf life
limited shelf life, expiry date on the label
packaging
pkg of 100 mg
manufacturer/tradename
BP
storage condition
dry at room temperature
color
off-white
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
eMolecules RITONAVIR | 155213-67-5 | MFCD00927142 | 5g | -- | ₹ 19,912.86 | ||
Ritonavir Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 14,035.30 | ||
Selleck Chemical LLC Ritonavir 10mg 155213-67-5 ABT-538, A 84538 | -- | ₹ 15,699.60 | ||
Sigma Aldrich Fine Chemicals Biosciences Ritonavir European Pharmacopoeia (EP) Reference Standard | 155213-67-5 | | -- | ₹ 24,531.07 | ||
Ritonavir | -- | ₹ 40,756.13 | ||
Ritonavir | -- | ₹ 15,966.88 | ||
Ritonavir for peak identification | -- | ₹ 15,966.88 | ||
Ritonavir | -- | ₹ 1,513.00 - ₹ 1,34,657.00 | ||
155213-67-5 | 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)- | -- | ₹ 1,246.00 - ₹ 61,410.00 |
Related Products
Description
- General description: Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.[1]
- Application: Ritonavir BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Ritonavir Oral SolutionRitonavir Tablets
- Packaging: Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable